Objective. To provide a comprehensive analysis of the descriptive epidemiology of invasive cervical cancer in Latin America and the Caribbean by analyzing quality data from the area's cancer registries, including data that were excluded from the International Agency for
Cancer registries play an important role in building infrastructure for essential health research, producing statistics on disease occurrence, and monitoring trends in cancer incidence by collecting, coding, and classifying cancer cases (5, 6) . The International Agency for Research on Cancer (IARC) has published data from population-based cancer registries routinely since the 1970s. Its publication, Cancer Incidence in Five Con-
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Original research tinents (CI5), records the worldwide burden of cancer by compiling comparable cancer incidence data from a wide range of geographic locations. The CI5 covers 5-year periods, most recently from 1998-2002 (5) . Prior to publication, the IARC invites cancer registries to submit their data to CI5 editors (5) . Data quality is then evaluated by an editorial board using IARC international standards and defined quality criteria (5, 7) . The indicators used by CI5 editors to assess the comparability, validity, and completeness of registry data are based on data used to estimate overall cancer rates, from all cancer sites combined, during the assessment period (5, 7) . Therefore, if a registry submits data that does not meet quality criteria for all cancer sites combined, data from the entire cancer registry will be excluded, regardless of the quality of the data available for any individual cancer site. Since they are often lethal or difficult to diagnose, certain cancers-such as pancreatic, liver, and esophageal-may lower overall data quality when combined with other cancer sites (8) (9) (10) .
Cervical cancer and its precursor lesions, on the other hand, are potentially more easily diagnosed, and therefore, data quality may be higher for this cancer site. The uterine cervix is accessible for physical examination and detection of early cervical precursor lesions. Furthermore, cervical cancer and its precursor lesions have well-established diagnostic criteria and available technologies for detection and diagnosis, such as cytology-based screening (11) . Although few organized cervical cancer screening programs exist in Latin America and the Caribbean, opportunistic screening programs have been implemented, thereby increasing cervical cancer awareness in the area (12, 13) .
In Latin America and the Caribbean, 29 cancer registries from 11 countries submitted data to IARC for inclusion in CI5 Volume IX (CI5-IX); however, only 11 registries from 8 countries were actually included (5) . Data from 18 registries were excluded by CI5-IX due to insufficient data quality for all cancer sites combined. Given the current level of interest in cervical cancer burden and prevention, the 11 registries included in CI5-IX may only partially represent the cancer incidence in different geographic areas within Latin America and the Caribbean. Evaluation of information from more cancer registries may lead to a better understanding of the profile and descriptive epidemiology of cervical cancer in this part of the world.
The study objective was to provide a comprehensive analysis of the descriptive epidemiology of invasive cervical cancer based on data from population-based cancer registries in Latin America and the Caribbean that were both included and excluded from CI5-IX, after first ascertaining that the quality of cervical cancer reporting was adequate. Any systematic variation in incidence rates among included and excluded registries was determined by examining age-standardized, histopathology-specific, and age-specific rates.
METHODS
This was a descriptive epidemiologic study. Invitation letters requesting permission to evaluate invasive cervical cancer data were sent to all 29 cancer registries in Latin America and the Caribbean that had submitted data to the CI5-IX. Of those, 20 granted permission for this analysis; 9 did not. Of the 20 granting permission, 9 had been included in CI5-IX (Bahía Blanca, Argentina; Brasília, Brazil; Cuiabá, Brazil; Goiânia, Brazil; São Paulo, Brazil; Cali, Colombia; Costa Rica; Quito, Ecuador; and Trujillo, Peru), and 11 had been excluded (Curitiba, Brazil; Fortaleza, Brazil; João Pessoa, Brazil; Salvador, Brazil; Cuba; Santiago de Cuba, Cuba; Villa Clara, Cuba; Guatemala; Arequipa, Peru; Lima, Peru; and Trinidad and Tobago). Figure 1 shows the process used to decide which registries would be included in the present study analysis. Each cancer registry provided annual data on invasive cervical cancer cases and corresponding population estimates. The Institutional Review Board at the University of Michigan (Ann Arbor, Michigan, United States) approved the study proposal.
Statistical analyses were performed with Microsoft Excel™ (Microsoft Corp., Redmond, Washington, United States) and SAS/STAT software (Version 9; SAS Institute, Cary, North Carolina, United States). First, a quality assessment was conducted using only invasive cervical cancer data to determine whether each registry had sufficient data quality.
International standards for quality criteria were employed. The same quality indicators used by IARC for all cancer sites combined in CI5-IX were used to examine the quality of cervical cancer data (5, 7 The acceptable limits for data quality indicators were based on international standards and modified by the authors to better reflect cervical cancer data: MV%, 75%-98%; DCO%, < 10%; and UB < 10%. It should be noted that while a high MV% is desirable in developed countries, a value that is near perfect in developing countries suggests an overreliance on pathology laboratories in diagnosing cervical cancer cases, and an inability to locate cases diagnosed by other means (14) . The cervical cancer-specific quality assessment was performed on all registries that had been either included in or excluded from the CI5-IX publication. Subsequent analyses were performed on all registries that met the necessary quality criteria for cervical cancer data. Age-standardized cervical cancer incidence rates were calculated for each population-based cancer registry over the 5-year time period 1998-2002 (the same years covered by CI5-IX), and were expressed as the number of new cervical cancer cases per 100 000 women per year (5, 15) . Histopathology-specific age-standardized incidence rates were calculated for each of the two most common histopathologic types of cervical cancer, squamous cell carcinoma (SCC) and adenocarcinoma (ADC) (16), using the method described above. Associated 95% Confidence Intervals (95%CI) were approximated based on the assumption of normally distributed rates (5, 15) .
Crude, age-specific incidence rates for cervical cancer were calculated for women 15-64 years of age. No cervical cancer cases were reported in women < 15 years of age in the registries analyzed. Incidence rates for women > 64 years of age were not calculated due to the sharp decline in incidence rates observed among older age groups in many registries. This fall-off of cervical cancer incidence rates at older ages may indicate under-ascertainment of cases in those age groups, and therefore, the age-specific incidence rates for these age groups were disregarded (17, 18) .
The effect of CI5-IX inclusion status on registry-specific cervical cancer incidence rates (i.e., to compare whether or not the rates for registries included in CI5-IX differ significantly from those excluded) was examined using a generalized linear mixed model. This model was designed to estimate the betweenregistry variation in cervical cancer incidence among the population-based cancer registries under study. The final model for registry-specific cervical cancer incidence rates included the following covariates: year, age group, an interaction term for year and age group, and inclusion status. Data from two of the three Cuban cancer registries (Santiago de Cuba and Villa Clara) were removed from this regression analysis because of the overlap in cases with the national cancer registry of Cuba. Regression models were generated using the GLIMMIX procedure in SAS/STAT ® software. Table 1 highlights the results from the cervical cancer-specific data quality assessment undergone by each of the 20 participating cancer registries. All 9 registries that had been included in CI5-IX met the cervical cancer-specific quality requirements, as did 5 of the 11 excluded registries. Of the 6 that did not meet the quality requirements and were removed from the analysis, 3 exceeded the ac- ) , and 1 was a hospital-based rather than population-based cancer registry (Guatemala). While these registries did not meet this study's requirements, they may be suitable for the needs of other studies at a local level. In all, a total of 14 population-based cancer registries met the necessary quality requirements for cervical cancer diagnosis and were analyzed in this study.
RESULTS
In Table 2 , age-standardized cervical cancer incidence rates are provided for the 14 Latin American and Caribbean population-based cancer registries under study. These rates demonstrated a wide range of values (14.6-44.0 per 100 000 women per year). The Trujillo, Peru registry, included in CI5-IX, reported the highest age-standardized rate, 44.0; while Villa Clara, Cuba, a registry excluded from CI5-IX, reported the lowest rate, 14.6. The highest rates (33.9-44.0) were reported by registries included in CI5-IX: Goiânia, Brazil; Brasília, Brazil; Cuiabá, Brazil; and Trujillo, Peru; however, the intermediate rates (22.4-33.1) were reported mostly by registries that had been excluded from CI5-IX (Lima, Peru; Santiago de Cuba, Cuba; and Fortaleza, Brazil). The lowest rates (14.6-21.1) were reported by an assortment of registries, some of which had been included in CI5-IX, and some, excluded.
When incidence rates were compared between pairs of registries, most rates were significantly different from the other (data not shown).
Age-standardized incidence rates for the two most prevalent histopathologic types of cervical cancer, squamous cell carcinoma (SCC) and adenocarcinoma (ADC), are also given in Table 2 . Rates ranged from 9.1-37.3 for cervical SCC, and 1.1-3.6 for cervical ADC. Similar to results for overall cervical cancer incidence, Trujillo, Peru, reported an SCC incidence rate of 37.3, the highest; while Villa Clara, Cuba, reported 9.1, the lowest. Brasília, Brazil, reported the highest ADC incidence rate, 5.0; while Villa Clara, Cuba, reported the lowest, 1.1.
In Figure 2 , age-specific cervical cancer incidence curves are illustrated for each registry. Across the 14 registries examined, the incidence of cervical cancer generally increases with age, as expected. However, the patterns of age-specific incidence curves fluctuated considerably. Some curves rise consistently as age increases, while others rise sharply and level off at older age groups; this phenomenon could be related to the under-ascertainment of cervical cancer cases in older age groups (17, 18) .
The generalized linear mixed model shows that after controlling for year and age group, the mean cervical cancer incidence rates were 10.4% higher for those registries that had been included in CI5-IX than for those excluded; however, these results were not statistically significant (b = 0.099, P = 0.541). Furthermore, the estimated variance between registries (0.050) was smaller than the variance among different age groups within each registry (0.557).
DISCUSSION
Using incidence data from 14 population-based cancer registries across Latin America and the Caribbean, this study provided a comprehensive analysis of invasive cervical cancer incidence among registries included and excluded by CI5-IX. This is the first study to examine variation in cervical cancer incidence among this large a number of Latin American and Caribbean cancer registries for the time period 1998-2002. By observing age-standardized, histopathology-specific, and age-specific cervical cancer incidence rates, heterogeneity among registries was found, confirming the heterogeneity found in prior studies (19) (20) (21) . These results highlight the importance of examining data from as many registries as possible when characterizing risk across a geographic area, and emphasize the usefulness of incidence data, particularly in resourcepoor areas.
Age-standardized incidence rates demonstrated a wide range of values (14.6-44.0), as did histopathologyspecific rates (SCC: 9.1-37.3; ADC: 1.1-3.6) and age-specific rates ( Table 2 ). The heterogeneity in cervical cancer incidence rates among the registries examined may be related to the data quality of each cancer registry (15) ; however, it may also be influenced by the presence or absence of organized screening Original programs within the geographic areas covered by these registries, as well as differences in the prevalence of cervical cancer risk factors (12) . Furthermore, geographic variation may exist in the efficiency of health care systems, where access to diagnostic and treatment facilities for all socioeconomic levels could vary accordingly; this might also contribute to the heterogeneity found in this study (7) . Across the Latin America and the Caribbean, screening practices vary widely. Costa Rica has had opportunistic cytological screening available since the 1970s, but a national screening program did not begin until 1995 (12) . Brazil launched a national cytology-based cervical cancer screening program in 1998; however, this program has only been considered successful in a few areas of Brazil (12) . Peru, a country with some of the highest cervical cancer incidence rates in Latin America and the Caribbean, has made cervical cancer a national priority for decades; however, despite creating a national plan in 1998 that outlined strategies for cervical cancer prevention, low screening coverage persists (22, 23) . Argentina also created a national program against cervical cancer in 1998, which was never fully implemented; therefore, in 2008 a national project improvement program began (24) . Future research needs to further elucidate the effect of cervical cancer screening programs, both organized and opportunistic, on cervical cancer incidence in the Region.
The CI5 publications routinely report on cancer incidence in Latin America and the Caribbean; however, a disproportionate number of registries in developing countries have been excluded due to inadequate data quality (5) . As technology advances and registration practices become more efficient, data quality has improved (5), but many cancer registries in developing countries have not had the opportunity to take advantage of such technological advances especially in comparison with more developed countries (6) . Furthermore, financial support for cancer registries in developing countries is often inconsistent. Since many registries rely heavily on government funding, changes in the local political climate easily threaten the sustainability of cancer registries in developing countries. Without funding, cancer registries may be forced to suspend registration-related activities until new sources of funding can be obtained, which may severely impact data continuity and quality. Increasing the utilization of low-cost technology, such as webbased cancer registration, and securing long-term, stable sources of funding may improve the overall data quality of cancer registries in developing countries.
A potential limitation of this study is that only two registries had nationwide coverage (Costa Rica and Cuba); all others were cancer registries covering large, urban centers. Also, women living in rural areas were not represented because there are no cancer registries for rural parts of Latin America and the Caribbean. As a result, the findings and conclusions of this study should only be generalized to urban women. However, despite an inability to document cervical cancer incidence in rural areas, it can be assumed that rates for late-stage cervical cancers are higher in rural than in urban areas. In rural areas, where cervical cancer screening facilities are limited and pre-cancerous cervical lesions are more likely to go undetected, a larger number of late-stage, invasive cervical cancers would be expected. To accurately assess cervical cancer incidence among women in Latin America and the Caribbean, more cancer registries should be implemented in rural areas.
Additional limitations should be considered. Only 20 of the 29 cancer registries included in CI5-IX granted permission for use of their data in this study. Had a larger number of registries been analyzed, it is likely that greater heterogeneity would have been seen. Despite performing a cervical cancerspecific quality assessment to ensure that only high quality cervical cancer data were included, data provided by registries excluded from CI5-IX should be interpreted with caution, as they may not represent valid or reliable estimates of cervical cancer incidence (5). Nonetheless, this analysis broadens the understanding of the cervical cancer profile in Latin America and the Caribbean.
One of this study's strengths is its methodology-a novel approach that first assessed the quality of the cervical cancer-specific data of each cancer registry. This permitted a greater number of Latin American and Caribbean registries to be included in the analysis than were in the CI5-IX, and yet, it is unlikely that quality was compromised.
The study's comparative nature is also a strength. Much can be learned about cervical cancer prevention and control by comparing cervical cancer incidence rates within such a geographically diverse area. Lessons learned from this study could be applied to other low-to middle-income countries where limited data are available. Additionally, similar analyses could be performed for other cancer sites, especially if those cancers are considered preventable and of high priority for public health policy.
Conclusions
Cervical cancer incidence rates in Latin America and the Caribbean vary greatly by geographic area. The full extent of this variation is not apparent in the CI5-IX, which includes only 11 cancer registries and excludes 18. The current study, however, provides a more complete picture of cervical cancer incidence by using existing data, conducting a data quality assessment, and performing an in-depth evaluation of one cancer site (cervical cancer). Therefore, we recommend using any population-based cancer registries (that have passed a quality assessment) in low-and middle-income countries to better understand cancer distribution, screening programs, and health care systems, and thereby enable Region-specific recommendations on cancer control and prevention interventions.
